Luca Filippi | Pediatria | Excellence in Research

Luca Filippi | Pediatria | Excellence in Research

Professor at University of Pisa, Italy.

Prof. Luca Filippi is an Italian pediatrician and neonatologist with over 30 years of experience in neonatal care and pediatric medicine. As an Associate Professor of Pediatrics at the University of Pisa and the Director of Neonatology and Neonatal Intensive Care, Prof. Filippi has dedicated his career to advancing medical care for infants and children. His work has primarily focused on neonatal resuscitation, intensive care, and the treatment of high-risk pediatric cases. He holds multiple medical specializations, including Pediatrics, Neonatology, and Anesthesiology and Resuscitation, with his medical journey marked by academic honors and recognized clinical expertise. Alongside his medical practice, Prof. Filippi has a longstanding commitment to teaching and mentorship, contributing to pediatric and neonatal resuscitation training for future medical professionals. His contributions to pediatric health extend internationally, with clinical internships and collaborations across Europe, reinforcing his influence in neonatal medicine.

Professional Profile

Education

Prof. Filippi’s academic journey began with his medical degree from the University of Florence in 1990, where he graduated with top honors (110/110 cum laude). Following his qualification as a Medical Doctor, he pursued multiple specializations to enhance his medical knowledge and practice in child health. He completed his specialization in Pediatrics in 1994 and later earned a specialization in Neonatology from the University of Siena in 2000, both with honors. Furthering his expertise, he specialized in Anesthesiology and Resuscitation at the University of Florence in 2005, also graduating with high distinction. Prof. Filippi then achieved his Ph.D. from Maastricht University’s Faculty of Health, Medicine, and Life Sciences in 2019, reflecting his commitment to academic excellence and research. His additional training includes certifications in Neonatal Intensive Care and Neonatal Ultrasonography, broadening his competencies and equipping him with the specialized skills necessary for high-stakes pediatric care.

Professional Experience

Throughout his career, Prof. Filippi has held numerous prestigious roles, both as a practitioner and academic. He began his medical journey as a neonatologist, working across various hospitals in Italy, including Careggi University Hospital, Siena University Hospital, and “Anna Meyer” University Children’s Hospital in Florence, where he served in neonatal intensive care. Since 2020, he has been an Associate Professor in Pediatrics at the University of Pisa and has led the university’s Neonatology and Neonatal Intensive Care unit. His career has seen him actively involved in high-risk neonatal care, combining clinical work with educational responsibilities. Additionally, his early internships at Meyer Hospital, Florence, and prestigious institutions in Paris and Belgium provided him with valuable international experience, fostering a global perspective in pediatric healthcare.

Research Interests

Prof. Filippi’s research interests focus on neonatal and pediatric critical care, neonatal resuscitation, and intensive care methodologies. He has a keen interest in developing improved resuscitation techniques for newborns and advancing protocols to reduce neonatal morbidity and mortality. Prof. Filippi also explores innovative treatments for high-risk neonates, especially in managing respiratory complications and metabolic disorders. His work often crosses interdisciplinary boundaries, bringing together pediatrics, anesthesiology, and neonatology. Additionally, he is interested in translational research, aiming to bridge the gap between clinical findings and practical applications in neonatal care. His recent research aims to enhance survival rates for premature infants through cutting-edge technologies and evidence-based medical practices.

Research Skills

Prof. Filippi possesses advanced research skills in clinical neonatology, neonatal intensive care, and pediatrics. He is proficient in designing and conducting clinical trials, interpreting complex medical data, and employing neonatal ultrasonography in clinical research. His research skills are complemented by a strong foundation in statistical analysis, which he uses to validate clinical findings and improve the reliability of his studies. Prof. Filippi is also skilled in interdisciplinary research, often collaborating with medical professionals from various fields to develop comprehensive solutions for neonatal health. Additionally, he is experienced in the ethical considerations of clinical research involving infants, ensuring patient safety and adherence to international standards.

Awards and Honors

Prof. Filippi’s career has been decorated with numerous awards and honors, recognizing his excellence in pediatric and neonatal care. He graduated cum laude in multiple specializations, including his medical degree and subsequent certifications in Pediatrics, Neonatology, and Anesthesiology. In 2014, he earned the prestigious National Scientific Qualification as an Associate Professor, which was renewed in 2018, followed by a qualification for Full Professor. His appointment as Associate Professor at the University of Pisa in 2020 underscores his exceptional contributions to medical education and practice. His distinguished career and dedication to neonatology have positioned him as a respected figure in the field, honored both by peers and academic institutions for his commitment to advancing pediatric healthcare.

Conclusion

Prof. Luca Filippi presents an impressive profile for the Research for Excellence in Research Award. His high level of clinical expertise, academic achievements, and leadership in neonatal intensive care make him a strong candidate. Addressing the noted areas for improvement could further elevate his profile.

Publications Top Notes

Agonism of β3-Adrenoceptors Inhibits Pathological Retinal Angiogenesis in the Model of Oxygen-Induced Retinopathy
Authors: Melecchi, A., Canovai, A., Amato, R., Bagnoli, P., Cammalleri, M.
Year: 2024
Journal: Investigative Ophthalmology and Visual Science, 65(10), 34
Citations: 0

Protective Effects of Beta-3 Adrenoceptor Agonism on Mucosal Integrity in Hyperoxia-Induced Ileal Alterations
Authors: Nardini, P., Zizi, V., Molino, M., Filippi, L., Pini, A.
Year: 2024
Journal: Antioxidants, 13(7), 863
Citations: 0

β3-adREnoceptor Analysis in CORD Blood of Neonates (β3 RECORD): Study Protocol of a Pilot Clinical Investigation
Authors: Scaramuzzo, R.T., Crucitta, S., del Re, M., Pini, A., Filippi, L.
Year: 2024
Journal: Life, 14(6), 776
Citations: 0

Implementation of Listening Visits with Parents of Preterm Infants in an Italian Neonatal Intensive Care Unit
Authors: Scabia, A., Chorna, O., Rocchitelli, L., Filippi, L., Guzzetta, A.
Year: 2024
Journal: MCN The American Journal of Maternal/Child Nursing, 49(3), 151–156
Citations: 0

Propranolol: a new pharmacologic approach to counter retinopathy of prematurity progression
Authors: Pascarella, F., Scaramuzzo, R.T., Pini, A., Ciantelli, M., Filippi, L.
Year: 2024
Journal: Frontiers in Pediatrics, 12, 1322783
Citations: 3

The genetic variant SLC2A1 -rs1105297 is associated with the differential analgesic response to a glucose-based treatment in newborns
Authors: Farinella, R., Falchi, F., Tavanti, A., Rizzato, C., Campa, D.
Year: 2024
Journal: Pain, 165(3), 657–665
Citations: 0

β-Adrenoceptors in Cancer: Old Players and New Perspectives
Authors: Amato, R., Lucchesi, M., Marracci, S., Filippi, L., Dal Monte, M.
Year: 2024
Book Chapter: Handbook of Experimental Pharmacology, 285, 665–688
Citations: 0

A promising case of preclinical-clinical translation: β-adrenoceptor blockade from the oxygen-induced retinopathy model to retinopathy of prematurity
Authors: Cammalleri, M., Filippi, L., Dal Monte, M., Bagnoli, P.
Year: 2024
Journal: Frontiers in Physiology, 15, 1408605
Citations: 0

β3 Adrenoceptor Agonism Prevents Hyperoxia-Induced Colonic Alterations
Authors: Filippi, L., Nardini, P., Zizi, V., Crociani, O., Pini, A.
Year: 2023
Journal: Biomolecules, 13(12), 1755
Citations: 3

Lung UltrasouNd Guided surfactant therapy in preterm infants: an international multicenter randomized control trial (LUNG study)
Authors: Corsini, I., Rodriguez-Fanjul, J., Raimondi, F., Vento, G., Dani, C.
Year: 2023
Journal: Trials, 24(1), 706
Citations: 3

 

Runhui Wu | Pediatric Hemostasis | Best Researcher Award

Prof. Runhui Wu | Pediatric Hemostasis | Best Researcher Award 

Director of hematology department at Beijing Children’s Hospital , China.

Dr. Runhui Wu is a distinguished expert in pediatric hematology, serving as the Director of the Hematology Department at Beijing Children’s Hospital, Capital Medical University, China. With over three decades of experience, Dr. Wu has made significant contributions to the management and treatment of hemophilia and other bleeding disorders in children. She has played a pivotal role in establishing comprehensive care programs for hereditary coagulation disorders and pediatric immune thrombocytopenia (ITP) in China. Her research focuses on individualized prophylaxis for severe hemophilia, immunologic tolerance in hemophilia, and the genetic diagnosis of coagulation factor deficiencies. Dr. Wu’s extensive publication record, leadership in national and international collaborative efforts, and numerous awards, including the Chinese Medical Science and Technology Award, highlight her impact on advancing pediatric hematology. Her work has significantly improved the quality of life for children with bleeding disorders, making her a leading figure in her field.

Profile

Education

Dr. Runhui Wu’s educational journey is rooted in a deep commitment to medical excellence, beginning with her Bachelor’s degree in Medicine from Capital Medical University, completed in 1991. She continued her advanced studies at the same institution, earning a Master’s degree in Medicine in 2005. Dr. Wu’s pursuit of knowledge culminated in a Doctor of Medicine (M.D.) degree from Capital Medical University in 2011. Throughout her academic journey, Dr. Wu honed her expertise in hematology, laying the foundation for her future contributions to the field. Her education, marked by rigorous training and a passion for pediatric hematology, has played a pivotal role in shaping her distinguished career, enabling her to lead innovative research and clinical advancements in the treatment of hemophilia and other blood disorders in children.

Professional Experience

Dr. Runhui Wu is a distinguished hematologist and Director of the Hematology Department at Beijing Children’s Hospital, Capital Medical University. With an extensive career dedicated to pediatric hematology, Dr. Wu has significantly contributed to the management and treatment of hemophilia and other hereditary coagulation disorders. She has been instrumental in establishing specialized outpatient clinics for hemophilia in children, creating a comprehensive treatment team that has gained national recognition. Her leadership extends to directing the pediatric group of the Hemophilia Treatment Center Collaborative Network of China (HTCCNC) and serving as the Associated Director of the Hematology Department at China’s Commission of Health. Additionally, Dr. Wu has been a key figure in national and international research collaborations, focusing on individualized prophylaxis in children with severe hemophilia A. Her work has led to the publication of numerous peer-reviewed articles and significant advancements in pediatric hematology care in China.

Research Interest

Dr. Runhui Wu’s research interests primarily focus on pediatric hematology, with a specific emphasis on hemophilia and other bleeding disorders. Her work explores the genetic diagnosis, pathogenesis, and prevention of coagulation factor deficiencies in children. Dr. Wu is particularly interested in individualized prophylactic treatments for severe hemophilia A, aiming to improve patients’ quality of life and reduce complications associated with the disease. She has also conducted significant research in pediatric immune thrombocytopenia (ITP), investigating novel therapeutic approaches and exploring the underlying mechanisms of the disease. Her contributions extend to the development of guidelines for the diagnosis and treatment of pediatric hematological disorders in China, reflecting her commitment to advancing both clinical practice and scientific knowledge in this field. Dr. Wu’s research is deeply intertwined with her dedication to improving healthcare outcomes for children with rare and complex blood disorders.

Research Skills

Dr. Runhui Wu possesses exceptional research skills in the field of pediatric hematology, with a focus on hemophilia and related bleeding disorders. His expertise spans genetic diagnosis, pathogenesis, and the development of innovative treatment strategies, particularly in the realm of individualized prophylaxis for children with severe hemophilia A. Dr. Wu has demonstrated proficiency in leading multidisciplinary research teams and securing significant funding for pioneering studies. His research contributions include exploring the role of immune tolerance in hemophilia and investigating the mechanisms of inhibitor development. Additionally, Dr. Wu has a strong publication record in top-tier journals, reflecting his ability to conduct rigorous scientific research and translate findings into clinical practice. His work has significantly advanced the understanding and management of pediatric hematological disorders, earning him recognition both nationally and internationally. Dr. Wu’s dedication to research and his collaborative approach have positioned him as a leader in the field of pediatric hematology.

Awards and Recognition

Dr. Wu has received multiple awards, including the Shanghai Science and Technology Award and the Chinese Medical Science and Technology Award. These accolades recognize her outstanding contributions to medical research and her influence on improving healthcare practices in China.

Conclusion

In conclusion, Dr. Runhui Wu is a strong candidate for the Best Researcher Award due to her extensive contributions to pediatric hematology, significant impact on healthcare practices in China, and her collaborative efforts in both national and international research. Her work has led to tangible improvements in patient care, making her a deserving recipient of this prestigious recognition.

Publications Top Notes

  • A long term outcomes analysis of severe haemophilia A boys receiving 4 years prophylaxis on the Chinese Haemophilia Individualized escalating low dose Prophylaxis (CHIPS)
    • Authors: Yao, W., Ai, D., Zhang, Q., Luke, K.-H., Wu, R.
    • Year: 2024
  • Surgical procedures and complications in placement of totally implantable venous access port in pediatric hemophilia patients: A retrospective analysis
    • Authors: Cheng, W., Zhang, J., Wang, X., Wu, R., Li, Z.
    • Year: 2024
  • The Differences of Serum Thrombopoietin Levels Between Acquired Aplastic Anemia and Immune Thrombocytopenia in Pediatric Patients
    • Authors: Chen, H., Ma, J., Ouyang, J., Wu, R., Chen, Z.
    • Year: 2024
  • Reduced doses of emicizumab achieve good efficacy: Results from a national-wide multicentre real-world study in China
    • Authors: Xu, Y., Wang, Y., Wu, R., Xue, F., Yang, R.
    • Year: 2024
  • The early and rapid response to daratumumab in children with chronic refractory immune thrombocytopenia from a referral single centre of China
    • Authors: Hu, Y., Wang, Z., Ma, J., Cheng, X., Wu, R.
    • Year: 2024
  • FOXO1 Single-Nucleotide Polymorphisms Are Associated with Bleeding Severity and Sensitivity of Glucocorticoid Treatment of Pediatric Immune Thrombocytopenia
    • Authors: Xie, X., Gu, H., Ma, J., Wu, R., Chen, Z.
    • Year: 2024
  • Clinical characteristics of eosinophilic lung diseases in children | 儿童肺嗜酸性粒细胞增多症的临床特征研究
    • Authors: Xu, X., Yin, J., Liu, J., Wu, R., Xu, B.
    • Year: 2024
  • Low-dose immune tolerance induction for severe hemophilia A inhibitor patients: Immunosuppressants are generally not necessary for inhibitor-titer below 200 BU/mL
    • Authors: Li, Z., Sun, J., Li, Z., Poon, M.-C., Wu, R.
    • Year: 2024
  • Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China
    • Authors: Wang, Z., Zhang, A., Xu, Z., Cheng, X., Wu, R.
    • Year: 2024
    • Citations: 1
  • HIF-1α induced by hypoxic condition regulates Treg/Th17 axis polarization in chronic immune thrombocytopenia
    • Authors: Gu, H., Wang, Z., Xie, X., Wu, R., Chen, Z.
    • Year: 2024